1. Regulatory effect of miR-195 in the placental dysfunction of preeclampsia
    Tuba Gunel et al, 2020, The Journal of Maternal-Fetal & Neonatal Medicine CrossRef
  2. Epigenetic signature associated with thyroid cancer progression and metastasis
    Hong Zhang et al, 2022, Seminars in Cancer Biology CrossRef
  3. Tet methylcytosine dioxygenase 2 suppresses renal cell cancer proliferation and metastasis by regulating the miR-200c-SCD axis
    BENJIANG QIAN et al, 2021, BIOCELL CrossRef
  4. MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer
    Amir Abbas Hamidi et al, 2022, Biomarker Research CrossRef
  5. Genetic polymorphisms of miRNA let7a‐2 and pri‐mir‐34b/c are associated with an increased risk of papillary thyroid carcinoma and clinical/pathological features
    Zahra Heidari et al, 2019, Journal of Cellular Biochemistry CrossRef
  6. Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling
    Hongchang Li et al, 2021, Aging CrossRef
  7. Down-regulated HSDL2 expression suppresses cell proliferation and promotes apoptosis in papillary thyroid carcinoma
    Jing Zeng et al, 2019, Bioscience Reports CrossRef
  8. Upregulation of circ_0000142 promotes multiple myeloma progression by adsorbing miR-610 and upregulating AKT3 expression
    Fang Liu et al, 2021, The Journal of Biochemistry CrossRef
  9. Exosome-mediated microRNA-497 delivery for anti-cancer therapy in a microfluidic 3D lung cancer model
    Kyeongsoo Jeong et al, 2020, Lab on a Chip CrossRef
  10. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis
    Yaowei Li et al, 2019, Journal of Ovarian Research CrossRef
  11. Downregulation of miR‑486‑5p in papillary thyroid carcinoma tissue: A study based on microarray and miRNA sequencing
    Dong‑Yue Wen et al, 2018, Molecular Medicine Reports CrossRef
  12. Circ_0000144 facilitates the progression of thyroid cancer via the miR‐217/AKT3 pathway
    Yi‐Xiang Fan et al, 2020, The Journal of Gene Medicine CrossRef
  13. MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment
    Maria Papaioannou et al, 2022, Frontiers in Oncology CrossRef
  14. Exosomal microRNA Therapy for Non-Small-Cell Lung Cancer
    Jibing Chen et al, 2023, Technology in Cancer Research & Treatment CrossRef
  15. MiR-16-5p inhibits breast cancer by reducing AKT3 to restrain NF-κB pathway
    Liwei Ruan et al, 2019, Bioscience Reports CrossRef
  16. MicroRNA‐16 functions as a tumor‐suppressor gene in oral squamous cell carcinoma by targeting AKT3 and BCL2L2
    Xi Wang et al, 2018, Journal of Cellular Physiology CrossRef
  17. MicroRNA-203 restrains epithelial–mesenchymal transition, invasion and migration of papillary thyroid cancer by downregulating AKT3
    Anmin You et al, 2020, Cell Cycle CrossRef